Munir Alam Receives Recognition from the Collaboration for AIDS Vaccine Discovery

Print

email this

July 9, 2010

Munir Alam, PhD received recognition as a Young and Early Career Investigator from the Collaboration for AIDS Vaccine Discovery (CAVD).  The CAVD established this monthly recognition to honor young and early career investigators who have made significant contributions to HIV vaccine research conducted within the CAVD.  Nominated by Dr. Barton Haynes of Duke University, Dr. Alam works on the Haynes Vaccine Discovery Consortia to understand the role of polyspecificity of broadly neutralizing MPER monoclonal antibodies and antibody membrane lipid binding in HIV-1 neutralization.  They have designed gp41 peptide-lipid conjugates using 4E10 and 2F5 epitope peptides to induce neutralizing antibodies against HIV and have found that viral membrane lipid binding may be a required initial step for HIV-1 neutralization by MPER neutralizing antibodies. In addition, they have conjugated immunogen-adjuvant complexes using toll like receptor agonists for induction of neutralizing antibodies against HIV.

The Collaboration for AIDS Vaccine Discovery (CAVD) is a scientific collaboration formed under the Global HIV Vaccine Enterprise in 2006.  Funded by the Bill and Melinda Gates Foundation, the CAVD has awarded grants to nineteen consortia comprised of scientists from around the world to facilitate the development of an HIV vaccine.  Dr. Barton Haynes, Director of the Duke Human Vaccine Institute, leads the Haynes Vaccine Discovery Consortia aimed at developing strategies for inducing neutralizing antibodies against HIV.
 
For more information on Dr. Alam’s work and this recognition, please visit: CAVD Young and Early Investigator Recognition.